Abraxane (paclitaxel in nanoparticle form, albumin-bound) 5 mg/ml, lyophilizate for suspension for infusion 20 ml (100 mg) or equivalent

The Zakarpattia Regional Antitumor Center, a municipal non-profit enterprise, is procuring Abraxane (paclitaxel in nanoparticle form, albumin-bound) or its equivalent for the treatment of cancer patients. The product is a lyophilizate for suspension for infusion, 20 ml (100 mg). The procurement is under an above-threshold tender. No specific qualifications or set-asides are mentioned. The contract value is not disclosed.